Aller au contenu principal

Recherche sur le site

Séminaire de Médecine Nucléaire

Outcome prediction to treatment with 177Lu-PSMA-RLT in men with metastatic castration resistant prostate cancer. Retrospective analysis from a monocentric cohort."